We are live on
!
Find out more
Mackenzie Financial Portfolio holdings
AUM
$83.3B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+15.19%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$46.3B
AUM Growth
+$6.05B
(+15%)
Cap. Flow
+$625M
Cap. Flow
% of AUM
1.35%
Top 10 Holdings %
Top 10 Hldgs %
20.02%
Holding
1,125
New
139
Increased
505
Reduced
364
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$186M |
| 2 |
Alcon
ALC
|
+$163M |
| 3 |
Akamai
AKAM
|
+$157M |
| 4 |
AbbVie
ABBV
|
+$120M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$273M |
| 2 |
FirstService
FSV
|
+$210M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$179M |
| 4 |
Synopsys
SNPS
|
+$137M |
| 5 |
Home Depot
HD
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.92% |
| 2 | Technology | 16.88% |
| 3 | Industrials | 13.41% |
| 4 | Healthcare | 10.72% |
| 5 | Consumer Discretionary | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Aurinia Pharmaceuticals
AUPH
$1.91B
| $169K | ﹤0.01% |
12,257
+407
| +3% | +$5.92K |
|
|
SVC
1002
Service Properties Trust
SVC
$1.04B
| $151K | ﹤0.01% |
+2,629
| New | +$134K |
|
|
RFP
1003
DELISTED
Resolute Forest Products Inc.
RFP
| $150K | ﹤0.01% |
+23,000
| New | +$125K |
|
|
GNMK
1004
DELISTED
GenMark Diagnostics, Inc
GNMK
| $150K | ﹤0.01% |
+10,300
| New | +$137K |
|
|
FLG
1005
Flagstar Bank National Association
FLG
$5.93B
| $149K | ﹤0.01% |
+4,700
| New | +$130K |
|
1006
Qfin Holdings
QFIN
$1.69B
| $141K | ﹤0.01% |
11,975
-255
| -2% | -$3.05K |
|
1007
Compañía de Minas Buenaventura
BVN
$7.69B
| $132K | ﹤0.01% |
10,843
-4,606
| -30% | -$56.2K |
|
|
CIM
1008
Chimera Investment
CIM
$1.04B
| $127K | ﹤0.01% |
4,127
-2,688
| -39% | -$77.8K |
|
|
SILV
1009
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $120K | ﹤0.01% |
10,794
-3,888
| -26% | -$36.5K |
|
|
OSG
1010
DELISTED
Overseas Shipholding Group Inc.
OSG
| $118K | ﹤0.01% |
55,014
+13,774
| +33% | +$28.7K |
|
|
ACB
1011
Aurora Cannabis
ACB
$173M
| $113K | ﹤0.01% |
1,362
+70
| +5% | +$5.1K |
|
1012
NexGen Energy
NXE
$6.06B
| $97K | ﹤0.01% |
35,454
-738
| -2% | -$1.48K |
|
|
EXK
1013
Endeavour Silver
EXK
$2.23B
| $88K | ﹤0.01% |
17,408
+262
| +2% | +$969 |
|
|
TRIB
1014
Trinity Biotech
TRIB
$7.83M
| $80K | ﹤0.01% |
+141
| New | +$70K |
|
1015
Information Services Group
III
$199M
| $70K | ﹤0.01% |
21,247
-2,163
| -9% | -$5.65K |
|
|
FLNT
1016
Fluent
FLNT
$102M
| $68K | ﹤0.01% |
+2,149
| New | +$42.2K |
|
1017
Harvard Bioscience
HBIO
$27.5M
| $67K | ﹤0.01% |
1,560
| – | – |
|
1018
Rimini Street
RMNI
$449M
| $65K | ﹤0.01% |
14,565
-4,067
| -22% | -$16.1K |
|
1019
DHI Group
DHX
$182M
| $64K | ﹤0.01% |
28,900
+5,900
| +26% | +$12.1K |
|
|
SUPV
1020
Grupo Supervielle
SUPV
$828M
| $63K | ﹤0.01% |
+29,600
| New | +$56K |
|
1021
Entravision Communication
EVC
$1.03B
| $56K | ﹤0.01% |
20,400
-12,000
| -37% | -$29K |
|
1022
SunCoke Energy
SXC
$720M
| $53K | ﹤0.01% |
12,100
-4,000
| -25% | -$16.7K |
|
|
TRUE
1023
DELISTED
TrueCar
TRUE
| $48K | ﹤0.01% |
11,500
| – | – |
|
1024
YPF
YPF
$206B
| $47K | ﹤0.01% |
10,100
-287,146
| -97% | -$1.27M |
|
|
AXU
1025
DELISTED
Alexco Resource Corp
AXU
| $47K | ﹤0.01% |
14,819
-931
| -6% | -$2.45K |
|
Similar funds
Mackenzie Financial's Q4 2020 Portfolio in Review
As of Q4 2020, Mackenzie Financial held 1,125 positions worth $46.3B, up 15% from $40.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Mackenzie Financial's Q4 2020 filing shows 139 new, 505 increased, 364 reduced and 91 closed positions. Its largest new stake was HealthEquity: 1,012,307 shares worth $70.6M. The largest sale was Baxter International, an estimated $273M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.
- Mackenzie Financial's largest Q4 2020 buy was HealthEquity: 1,012,307 shares worth $70.6M.
- Mackenzie Financial added most to Amphenol in Q4 2020, an estimated $186M increase.
- Mackenzie Financial's biggest Q4 2020 reduction was Baxter International, cutting an estimated $273M.
- Mackenzie Financial fully exited Vail Resorts in Q4 2020, selling an estimated $85M.
- Mackenzie Financial's ten largest holdings make up 20% of its $46.3B portfolio in Q4 2020.
- Mackenzie Financial opened 139 new positions and closed 91 in Q4 2020.
- Mackenzie Financial's portfolio value rose 15% quarter-over-quarter to $46.3B.
Based on Mackenzie Financial's 13F filing for Q4 2020, filed 10 Feb 2021.